MD
MiMedx Group, Inc.
MDXG · NASDAQ
$4.57 +3.63% (+$0.16)
1M +9.33%
Market Cap $645.7M
P/E Ratio 103.53x
Div. Yield -
ROE 2.61%
Bulios Fair Price
$5.82
27.4% upside
Trenutna cena
$4.57
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MDXG trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
50 /100
Fair P/E 103.53x
EV/EBITDA 21.58x
P/S 1.82x
Growth
94 /100
Growing Rev. growth 16.05%
Book val. growth 51.01%
EPS growth N/A
Profitability
48 /100
Moderate Gross margin 78.85%
Net margin 1.76%
Op. margin 2.46%
Quality
24 /100
Poor ROIC 1.94%
ROE 2.61%
ROA 2.22%
Debt
94 /100
Low Debt/Equity 0.01x
Current ratio 5.33x
Int. coverage 7.56x
Stability
48 /100
Moderate Beta 1.41x
Rev. volatility 6.63%
EPS volatility 143.90%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MDXG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph H. Capper
Employees
808
Headquarters
Marietta
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report